AGLagilon health, inc.
Price
+185%1YEnd-of-day closes, not the intraday tick.
Survival is the story here: start there
Quality mixed, hard red flags, growth steady, the market undecided.
Our business is transforming healthcare by empowering the primary care physicians (“PCP”) to be the agents for change in the communities they serve. We believe that PCPs, with their intimate patient-physician relationships, are best positioned to drive meaningful change in quality, cost and patient experience when provided with the right infrastructure and payment model. Through our combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, we believe we are poised to revolutionize healthcare for seniors across communities throughout the United States (“U.S.”).
In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
agilon health, inc. (AGL) reported revenue of $1.49B in Q2 2026 (quarter ended Jun 30, 2026), up 7.2% from the same quarter a year earlier. That came with net income of $18M (1.2% of revenue). For the full year FY2025, revenue was $5.93B (−2.1% year on year) and net income −$391M. Its largest product in Q2 2026 was Medical Services at $1.49B, 100% of the disclosed total, well ahead of Other Operating at 0.1%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 22, 2026On July 17, 2026, agilon health, inc. (the "Company") provided notice to Girish Venkatachaliah, the Company's Chief Technology Officer, that Mr. Venkatachaliah’s employment with the Company will terminate effective August 1, 2026 (the “Separation Date”)Director or officer change · Form 8-K
- Apr 27, 2026On April 24, 2026, agilon health, inc. (the “Company”) entered into an Employment Agreement (the “Employment Agreement”) with Tim O’Rourke, pursuant to which Mr. O’Rourke will serve as the Company’s Chief Executive Officer and President, reporting to the Board of Directors (the “Board”)Director or officer change · Form 8-K
- Mar 30, 2026To the extent required by.Shareholder rights modified · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $1.49BThe company’s own SEC segment disclosure.
- Medical Services$1.49B100%
- Other Operating$1.8M0%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.